Effect of apomorphine on peripheral venous gastrin and insulin levels in conscious dogs

Acta Physiologica Scandinavica
K Uvnäs-Wallensten, M Goiny

Abstract

Apomorphine 0.001, 0.005, 0.05 and 0.1 mg/kg were given i.v. to conscious dogs and gastrin and insulin levels were measured in peripheral venous blood. The lowest dose of apomorphine (0.01 mg/kg) did not change gastrin levels but some times caused a decrease of insulin levels, whereas the higher doses (0.005-0.1 mg/kg) induced a dose dependent increase of both hormone levels. The peak shaped release responses appeared within a few minutes and the basal values were reached again within 20 to 30 min. Apomorphine within the dose range which induced a response of insulin and gastrin also caused nausea and vomiting. After pretreatment with haloperidol (0.1 mg/kg) no signs of sickness were observed and the response of gastrin to 0.01 and 0.05 mg/kg of apomorphine was almost completely blocked, whereas the insulin response to both these dose was inhibited to approximately 50%. We conclude that the release of gastrin and insulin can be activated by stimulation of dopaminergic receptors, the anatomical location of which is not clear. Possible sites for the dopaminergic receptors are the hypothalamic region or the vagal centres in the medulla oblongata.

References

Jan 1, 1977·Acta Physiologica Scandinavica·K Uvnäs-WallenstenR Luft
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·K Uvnäs-WallenstenB Uvnäs
Oct 1, 1978·Physiological Reviews·R I Weiner, W F Ganong
Jan 1, 1975·The American Journal of Digestive Diseases·C L SmithK Buchanan
Feb 1, 1978·Acta Physiologica Scandinavica·K Uvnäs-Wallensten, G Nilsson
Dec 1, 1977·The American Journal of Medicine·J T La RossaJ C Melby
Feb 1, 1978·Acta Physiologica Scandinavica·K Uvnäs-WallenstenR Luft
Jul 1, 1978·Acta Physiologica Scandinavica·K Uvnäs-WallenstenS Efendic
Jul 1, 1977·Acta Physiologica Scandinavica·G Nilsson, K Uvnäs-Wallensten
May 1, 1976·Pharmacology, Biochemistry, and Behavior·G E Martin, R D Myers
Sep 7, 1974·Lancet·S R BloomR C Russell
Sep 1, 1967·The Journal of Pharmacy and Pharmacology·N E AndénT Hökfelt
Oct 1, 1974·Endocrinology·A KanetoK Kosaka
Sep 1, 1967·The Journal of Physiology·P M Daniel, J R Henderson
Jul 1, 1967·Diabetes·L A FrohmanR Javid
Mar 1, 1967·Endocrinology·A KanetoK Nakao
Jul 1, 1981·Acta Physiologica Scandinavica·K Uvnäs-WallenstenS Cekan
Jan 1, 1980·Scandinavian Journal of Gastroenterology·R CaldaraM Romussi

❮ Previous
Next ❯

Citations

Jan 1, 1983·European Journal of Clinical Pharmacology·R CaldaraC Barbieri
Jul 1, 1981·Acta Physiologica Scandinavica·K Uvnäs-WallenstenS Cekan
Feb 9, 2010·The Journal of Small Animal Practice·C ElwoodK Savary-Bataille
May 1, 1984·British Journal of Clinical Pharmacology·E MasciA Tittobello

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
B Libet, T Tosaka
Proceedings of the National Academy of Sciences of the United States of America
L I LarssonJ R Rehfeld
Acta Physiologica Scandinavica
K Uvnäs-WallenstenS Efendic
© 2021 Meta ULC. All rights reserved